In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.
about
Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapyTheranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy.Synthesis and Biological Evaluation of New Quinoxaline Derivatives of ICF01012 as Melanoma-Targeting Probes.PET and SPECT imaging of melanoma: the state of the art.
P2860
In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
In vivo efficacy of melanoma i ...... eteroarylcarboxamide molecule.
@en
In vivo efficacy of melanoma i ...... eteroarylcarboxamide molecule.
@nl
type
label
In vivo efficacy of melanoma i ...... eteroarylcarboxamide molecule.
@en
In vivo efficacy of melanoma i ...... eteroarylcarboxamide molecule.
@nl
prefLabel
In vivo efficacy of melanoma i ...... eteroarylcarboxamide molecule.
@en
In vivo efficacy of melanoma i ...... eteroarylcarboxamide molecule.
@nl
P2093
P2860
P50
P356
P1476
In vivo efficacy of melanoma i ...... heteroarylcarboxamide molecule
@en
P2093
Denise Donnarieix
Elisabeth Miot-Noirault
Florence Mishellany
Frédérique Penault-Llorca
Jacques Cluzel
Janine Papon
Michel Doly
Michèle Borel
Nathalie Jacquemot
Nicole Moins
P2860
P304
P356
10.1002/IJC.28103
P577
2013-03-18T00:00:00Z